Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Review explores how microRNAs (miRNAs) interact in cancer development, their potential in diagnosis, and innovative ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Moderna (NasdaqGS:MRNA) with a Market Perform ...

Melbourne scientists may have unlocked the mystery behind common but annoying mRNA vaccine side effects — such as headaches, ...

A new study published on Thursday by Melbourne's Peter Doherty Institute for Infection and Immunity and RMIT University ...

The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...

A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how ...